DnrK methyltransferase (DnrK)

DnrK is a bacterial methyltransferase enzyme found in several *Streptomyces* species. It participates in the biosynthetic pathway of anthracycline antibiotics such as daunorubicin, catalyzing a methylation step crucial for final antibiotic structure. It is not a therapeutic target in humans, nor is it a member of standard target classes like G protein-coupled receptors, ion channels, human kinases, or transcription factors. The abbreviation "DnrK" does not correspond to any human molecular target or disease-associated protein in standard biomedical reference databases. No clinical drugs are known to target DnrK, and it is not used as a biomarker or implicated in any human safety concern. Its principal role is in secondary metabolism of bacteria, with research relevance limited to understanding or engineering antibiotic biosynthesis. If you intended a different spelling or human target (e.g., a kinase, receptor), please clarify as "DnrK" does not correspond to any recognized therapeutic target in pharmacology or human medicine.

Other names

Daunorubicin biosynthesis methyltransferaseDNA methyltransferase (non-specific)